Ezekiel Olugbenga Iwalewa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ezekiel Olugbenga Iwalewa has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
A.A. Gbolade
1 shared publicationAbayomi M. Ajayi
Department of Pharmacology and Therapeutics, Neuropharmacology and Toxicology Unit, College of Medicine, University of Ibadan, Ibadan, Nigeria
1 shared publication- Abdullateef Isiaka Alagbonsi
University of Rwanda
1 shared publication - Adeyinka Aderonmu
Neuropharmacology and Cardiovascular Units, Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan
1 shared publication - Anoka A. Njan
African Institute of Science and Technology,Abuja,Nigeria, Nigeria
1 shared publication - Anthonia Soje
University of Ilorin, Department of Pharmacology and Therapeutics, Faculty of Basic Medical Sc, 240003, Ilorin, Nigeria
1 shared publication
Latest Publications
- Open Access
- 3 July 2025
- Published by Department of Pharmacology & Toxicology, Faculty of Pharmacy, University of Benin in Pharmacology and Toxicology of Natural Medicines
- Vol. 5 (3-4) , 19-28
Methanol Leaf Extract of Andrographis paniculata Reverses Behavioral and Neuro-biochemical Changes Induced by Chronic Restraint Stress in Mice
Background and Purpose: Chronic stress and behavioral activities have recently been linked with hyperglycemia. The neurobehavioral effect and neuro-biochemical changes following the administration of Andrographis paniculata leaf extract were evaluated in mice using the chronic stress paradigm. Methods: Male mice were assigned to 6 groups (n=6). Groups 1and 2 received distilled water and groups 3, 4, 5 were administered 80, 160 and 320 mg/kg of methanol extract of Andrographis paniculata (MEAP) respectively while group 6 which was the positive control was administered pioglitazone 15 mg/kg. All treatments were by the oral route. The animals were subjected to 4 cycles of restraint stress (2 h per day) in which a cycle lasted 10 days. Animals were stressed for 7 days and allowed to rest for 3 days. On the 39th day in the 4th cycle, animals were tested for neurobehavioral phenotypes: depression, anxiety and memory impairment. Blood was collected for corticosterone and insulin quantification, while the adrenal gland was weighed. Brains were collected for estimation of malondialdehyde (MDA), superoxide dismutase (SOD), catalase, (CAT), nitric oxide (NO), reduced glutathione (GSH), tumor necrosis factor-? (TNF-?), interleukin 6 (IL-6) and acetylcholinesterase (AchE). Results: MEAP reversed hyperglycemia caused by chronic restraint stress (CRS), reduced anxiety, and memory impairment. It caused an increase in the level of SOD with a corresponding reduction in the levels of NO. Adrenal weight were not significantly changed. The levels of MDA were not significantly reduced while the levels of GSH and CAT were not significantly elevated. MEAP also reduced CRS-induced elevation in corticosterone, AChE, TNF-?, and IL-6 levels and reversed CRS-induced decrease in serum insulin levels. Conclusion: The results suggest that the extract of Andrographis paniculata reversed the complications of hyperglycemia induced by exposure to chronic stress through the modulation of antioxidant system and reduction of pro-inflammatory cytokines.
- 3 July 2025
- Published by Department of Pharmacology & Toxicology, Faculty of Pharmacy, University of Benin in Pharmacology and Toxicology of Natural Medicines
- Vol. 5 (3-4) , 19-28
Open AccessMethanol Leaf Extract of Andrographis paniculata Reverses Behavioral and Neuro-biochemical Changes Induced by Chronic Restraint Stress in Mice
Background and Purpose: Chronic stress and behavioral activities have recently been linked with hyperglycemia. The neurobehavioral effect and neuro-biochemical changes following the administration of Andrographis paniculata leaf extract were evaluated in mice using the chronic stress paradigm. Methods: Male mice were assigned to 6 groups (n=6). Groups 1and 2 received distilled water and groups 3, 4, 5 were administered 80, 160 and 320 mg/kg of methanol extract of Andrographis paniculata (MEAP) respectively while group 6 which was the positive control was administered pioglitazone 15 mg/kg. All treatments were by the oral route. The animals were subjected to 4 cycles of restraint stress (2 h per day) in which a cycle lasted 10 days. Animals were stressed for 7 days and allowed to rest for 3 days. On the 39th day in the 4th cycle, animals were tested for neurobehavioral phenotypes: depression, anxiety and memory impairment. Blood was collected for corticosterone and insulin quantification, while the adrenal gland was weighed. Brains were collected for estimation of malondialdehyde (MDA), superoxide dismutase (SOD), catalase, (CAT), nitric oxide (NO), reduced glutathione (GSH), tumor necrosis factor-? (TNF-?), interleukin 6 (IL-6) and acetylcholinesterase (AchE). Results: MEAP reversed hyperglycemia caused by chronic restraint stress (CRS), reduced anxiety, and memory impairment. It caused an increase in the level of SOD with a corresponding reduction in the levels of NO. Adrenal weight were not significantly changed. The levels of MDA were not significantly reduced while the levels of GSH and CAT were not significantly elevated. MEAP also reduced CRS-induced elevation in corticosterone, AChE, TNF-?, and IL-6 levels and reversed CRS-induced decrease in serum insulin levels. Conclusion: The results suggest that the extract of Andrographis paniculata reversed the complications of hyperglycemia induced by exposure to chronic stress through the modulation of antioxidant system and reduction of pro-inflammatory cytokines.
- Open Access
- 16 October 2024
- Published by Elsevier in Current Research in Physiology
- Vol. 7, 100132
Yeast supplementation potentiates fluoxetine's anti-depressant effect in mice via modulation of oxido-inflammatory, CREB, and MAPK signaling pathways
- 16 October 2024
- Published by Elsevier in Current Research in Physiology
- Vol. 7, 100132
Open AccessYeast supplementation potentiates fluoxetine's anti-depressant effect in mice via modulation of oxido-inflammatory, CREB, and MAPK signaling pathways
- Open Access
- 31 January 2024
- Published by University of Dar es Salaam - DIGITAL COMMONS JOURNALS in Tanzania Journal of Science
- Vol. 49 (5) , 930-942
Evaluation of the Modulatory Effects of Capsicum Chinensis Methanol Extract in Streptozotocin-Induced Diabetic Neuropathic Pain in Mice
Diabetes is one of the common causes of neuropathic pain. The first-line treatment drugs used in alleviating neuropathic pain can cause adverse effects. Therefore, the aim of this study is to evaluate the analgesic property of Capsicum chinensis, since the plant was reported to be used against chronic pain in traditional medicine. Streptozotocin-induced diabetes was adopted to model neuropathy in mice and the antihyperalgesic effect of the extract was evaluated using a hot plate test, cold allodynia test, and Randall- Selitto paw pressure test. The plasma level of pain-associated inflammatory biomarkers like interleukin-6 (IL-6) and tissue necrotic factor-α (TNF-α) was also measured. Treatment with varying doses of extract (1, 2.5, and 5 mg/kg) significantly (p < 0.05) increased the mean reaction time to thermal pain during hot and cold plate tests. During the Paw pressure test, reaction time was significantly prolonged in the treatment groups and the plasma level of TNF-α and IL-6 were reduced (p < 0.05). The extract showed a better antihyperalgesic effect than the positive control drug (gabapentin). The result obtained showed that Capsicum chinensis extract can alleviate diabetes neuropathic pain in mice models with a better analgesic effect thanthe control drug (gabapentin).
- 31 January 2024
- Published by University of Dar es Salaam - DIGITAL COMMONS JOURNALS in Tanzania Journal of Science
- Vol. 49 (5) , 930-942
Open AccessEvaluation of the Modulatory Effects of Capsicum Chinensis Methanol Extract in Streptozotocin-Induced Diabetic Neuropathic Pain in Mice
Diabetes is one of the common causes of neuropathic pain. The first-line treatment drugs used in alleviating neuropathic pain can cause adverse effects. Therefore, the aim of this study is to evaluate the analgesic property of Capsicum chinensis, since the plant was reported to be used against chronic pain in traditional medicine. Streptozotocin-induced diabetes was adopted to model neuropathy in mice and the antihyperalgesic effect of the extract was evaluated using a hot plate test, cold allodynia test, and Randall- Selitto paw pressure test. The plasma level of pain-associated inflammatory biomarkers like interleukin-6 (IL-6) and tissue necrotic factor-α (TNF-α) was also measured. Treatment with varying doses of extract (1, 2.5, and 5 mg/kg) significantly (p < 0.05) increased the mean reaction time to thermal pain during hot and cold plate tests. During the Paw pressure test, reaction time was significantly prolonged in the treatment groups and the plasma level of TNF-α and IL-6 were reduced (p < 0.05). The extract showed a better antihyperalgesic effect than the positive control drug (gabapentin). The result obtained showed that Capsicum chinensis extract can alleviate diabetes neuropathic pain in mice models with a better analgesic effect thanthe control drug (gabapentin).
- Open Access
- 1 January 2019
- Published by Elsevier in Toxicology Reports
- Vol. 6, 496-504
Safety effect of fractions from methanolic leaf extract of Ocimum gratissimum on reproduction in male wistar rats
- 1 January 2019
- Published by Elsevier in Toxicology Reports
- Vol. 6, 496-504
Open AccessSafety effect of fractions from methanolic leaf extract of Ocimum gratissimum on reproduction in male wistar rats
- Open Access
- 20 May 2013
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 13 (1) , 1-111
Antimicrobial activity and cytotoxicity of triterpenes isolated from leaves of Maytenus undata (Celastraceae)
Background: Plants of the genus Maytenus belong to the family Celastraceae and are widely used in folk medicine as anti-tumour, anti-asthmatic, analgesic, anti-inflammatory, antimicrobial and anti-ulcer agents, and as a treatment for stomach problems. The aim of this study was to isolate and identify active compounds with antifungal activity from Maytenus undata after a preliminary study highlighted promising activity in crude extracts. Methods: Sequential extracts of M. undata leaves prepared using hexane, dichloromethane (DCM), acetone and methanol (MeOH) were tested for activity against Cryptococcus neoformans, a fungal organism implicated in opportunistic infections. Bioassay-guided fractionation of the hexane extract using C. neoformans as test organism was carried out to isolate antifungal compounds. The cytotoxicity of compounds isolated in sufficient quantities was evaluated using a tetrazolium-based colorimetric cellular assay (MTT) and a haemagglutination assay (HA). Results: The hexane extract was most active with an MIC of 20 μg/ml against C. neoformans. The triterpene compounds friedelin (1), epifriedelanol (2), taraxerol (3), 3-oxo-11α-methoxyolean-12-ene-30-oic acid (4), 3-oxo-11α-hydroxyolean-12-ene-30-oic acid (5) and 3,11-dihydroxyolean-12-ene-30-oic acid (6) were isolated. Compound 6 was isolated for the first time from a plant species. The antimicrobial activity of compounds 1, 3, 5 and 6 was determined against a range of bacteria and fungi implicated in opportunistic and nosocomial infections. Compounds 5 and 6 were the most active against all the tested microorganisms with MIC values ranging between 24 and 63 μg/ml, except against Staphylococcus aureus which was relatively resistant. Compounds 1 and 3 had a low toxicity with an LC50 > 200 μg/ml towards Vero cells in the MTT assay. Compounds 5 and 6 were toxic with LC50 values of 6.03±0.02 and 2.98±0.01 μg/ml, respectively. Compounds 1 and 3 similarly were not toxic to the red blood cells (RBCs) but compounds 5 and 6 were toxic, showing HA titer values of 1.33 and 0.67 respectively. Conclusions: Compounds 5 and 6 were the most active but were also relatively cytotoxic to monkey kidney cells and red blood cells, while the other isolated compounds were less active and less cytotoxic.
- 20 May 2013
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 13 (1) , 1-111
Open AccessAntimicrobial activity and cytotoxicity of triterpenes isolated from leaves of Maytenus undata (Celastraceae)
Background: Plants of the genus Maytenus belong to the family Celastraceae and are widely used in folk medicine as anti-tumour, anti-asthmatic, analgesic, anti-inflammatory, antimicrobial and anti-ulcer agents, and as a treatment for stomach problems. The aim of this study was to isolate and identify active compounds with antifungal activity from Maytenus undata after a preliminary study highlighted promising activity in crude extracts. Methods: Sequential extracts of M. undata leaves prepared using hexane, dichloromethane (DCM), acetone and methanol (MeOH) were tested for activity against Cryptococcus neoformans, a fungal organism implicated in opportunistic infections. Bioassay-guided fractionation of the hexane extract using C. neoformans as test organism was carried out to isolate antifungal compounds. The cytotoxicity of compounds isolated in sufficient quantities was evaluated using a tetrazolium-based colorimetric cellular assay (MTT) and a haemagglutination assay (HA). Results: The hexane extract was most active with an MIC of 20 μg/ml against C. neoformans. The triterpene compounds friedelin (1), epifriedelanol (2), taraxerol (3), 3-oxo-11α-methoxyolean-12-ene-30-oic acid (4), 3-oxo-11α-hydroxyolean-12-ene-30-oic acid (5) and 3,11-dihydroxyolean-12-ene-30-oic acid (6) were isolated. Compound 6 was isolated for the first time from a plant species. The antimicrobial activity of compounds 1, 3, 5 and 6 was determined against a range of bacteria and fungi implicated in opportunistic and nosocomial infections. Compounds 5 and 6 were the most active against all the tested microorganisms with MIC values ranging between 24 and 63 μg/ml, except against Staphylococcus aureus which was relatively resistant. Compounds 1 and 3 had a low toxicity with an LC50 > 200 μg/ml towards Vero cells in the MTT assay. Compounds 5 and 6 were toxic with LC50 values of 6.03±0.02 and 2.98±0.01 μg/ml, respectively. Compounds 1 and 3 similarly were not toxic to the red blood cells (RBCs) but compounds 5 and 6 were toxic, showing HA titer values of 1.33 and 0.67 respectively. Conclusions: Compounds 5 and 6 were the most active but were also relatively cytotoxic to monkey kidney cells and red blood cells, while the other isolated compounds were less active and less cytotoxic.
- Open Access
- 30 July 2008
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 3 (1) , 34
Clinical effects of Garcinia kola in knee osteoarthritis
Over the past years, there has been a growing number of knee osteoarthritis (KOA) patients who are not willing to comply with long-term non-steroidal anti-inflammatory drugs (NSAID) treatment and wish to use herbal anti- rheumatic medicine. This study assessed the clinical effects of Garcinia kola (GK) in KOA patients. Prospective randomized, placebo controlled, double blind, clinical trial approved by the institutional medical ethics review board and written informed consent obtained from each patient. All KOA patients presenting at the Obafemi Awolowo University Teaching Hospital complex were recruited into the study. The patients were grouped into four (A = Placebo, B = Naproxen, C = Garcinia kola, D = Celebrex). The drugs and placebo were given twice a day per oral route. Each dose consisted of 200 mg of G. kola, Naproxen (500 mg), Celebrex (200 mg) and Ascorbic acid (100 mg). The primary outcome measure over six weeks study period was the change in mean WOMAC pain visual analogue scales (VAS). Secondary outcome measures included the mean change in joint stiffness and physical function (mobility/walking). 143 patients were recruited, 84 (58.7%, males--24, females--60) satisfied the selection criteria and completed the study. The effect of knee osteoarthritis bilateralism among the subjects was not significant on their outcome (p > 0.05). The change in the mean WOMAC pain VAS after six weeks of G. kola was significantly reduced compared to the placebo (p < 0.001). Multiple comparisons of the mean VAS pain change of G. kola group was not lowered significantly against the naproxen and celebrex groups (p > 0.05). The onset of G. kola symptomatic pain relief was faster than the placebo (p < 0.001). However, it was slower than the active comparators (p > 0.05). The duration of therapeutic effect of Garcinia kola was longer than the placebo (p > 0.001). G. kola period of effect was less than naproxen and celebrex (p < 0.001). G. kola subjects had improved mean change mobility/walking after six weeks better than the control group(p < 0.001). The mean change in mobility of the G. kola group when compared to the active comparators was not significantly better (p < 0.05). The mean change of knee joint stiffness (p < 0.001) and the change of mean WOMAC score (p < 0.001) were improved on Garcinia kola as compared to the placebo. The mid term outcome of eleven Garcinia kola subjects after cessation of use had a mean pain relief period of 17.27 +/- 5.15 days (range: 9-26 days). There was no significant cardiovascular, renal or drug induced adverse reaction to Garcinia kola. Garcinia kola appeared to have clinically significant analgesic/anti-inflammatory effects in knee osteoarthritis patients. Garcinia kola is a potential osteoarthritis disease activity modifier with good mid term outcome. Further studies are required for standardization of dosages and to determine long-term effects.
- 30 July 2008
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 3 (1) , 34
Open AccessClinical effects of Garcinia kola in knee osteoarthritis
Over the past years, there has been a growing number of knee osteoarthritis (KOA) patients who are not willing to comply with long-term non-steroidal anti-inflammatory drugs (NSAID) treatment and wish to use herbal anti- rheumatic medicine. This study assessed the clinical effects of Garcinia kola (GK) in KOA patients. Prospective randomized, placebo controlled, double blind, clinical trial approved by the institutional medical ethics review board and written informed consent obtained from each patient. All KOA patients presenting at the Obafemi Awolowo University Teaching Hospital complex were recruited into the study. The patients were grouped into four (A = Placebo, B = Naproxen, C = Garcinia kola, D = Celebrex). The drugs and placebo were given twice a day per oral route. Each dose consisted of 200 mg of G. kola, Naproxen (500 mg), Celebrex (200 mg) and Ascorbic acid (100 mg). The primary outcome measure over six weeks study period was the change in mean WOMAC pain visual analogue scales (VAS). Secondary outcome measures included the mean change in joint stiffness and physical function (mobility/walking). 143 patients were recruited, 84 (58.7%, males--24, females--60) satisfied the selection criteria and completed the study. The effect of knee osteoarthritis bilateralism among the subjects was not significant on their outcome (p > 0.05). The change in the mean WOMAC pain VAS after six weeks of G. kola was significantly reduced compared to the placebo (p < 0.001). Multiple comparisons of the mean VAS pain change of G. kola group was not lowered significantly against the naproxen and celebrex groups (p > 0.05). The onset of G. kola symptomatic pain relief was faster than the placebo (p < 0.001). However, it was slower than the active comparators (p > 0.05). The duration of therapeutic effect of Garcinia kola was longer than the placebo (p > 0.001). G. kola period of effect was less than naproxen and celebrex (p < 0.001). G. kola subjects had improved mean change mobility/walking after six weeks better than the control group(p < 0.001). The mean change in mobility of the G. kola group when compared to the active comparators was not significantly better (p < 0.05). The mean change of knee joint stiffness (p < 0.001) and the change of mean WOMAC score (p < 0.001) were improved on Garcinia kola as compared to the placebo. The mid term outcome of eleven Garcinia kola subjects after cessation of use had a mean pain relief period of 17.27 +/- 5.15 days (range: 9-26 days). There was no significant cardiovascular, renal or drug induced adverse reaction to Garcinia kola. Garcinia kola appeared to have clinically significant analgesic/anti-inflammatory effects in knee osteoarthritis patients. Garcinia kola is a potential osteoarthritis disease activity modifier with good mid term outcome. Further studies are required for standardization of dosages and to determine long-term effects.
- 1 May 2008
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 117 (3) , 507-511
Anti-protozoan activities of Harungana madagascariensis stem bark extract on trichomonads and malaria
- 1 May 2008
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 117 (3) , 507-511
Anti-protozoan activities of Harungana madagascariensis stem bark extract on trichomonads and malaria
- 12 February 2005
- Published by Elsevier in Fitoterapia
- Vol. 76 (2) , 250-253
In vitro spasmolytic effect of aqueous extract of Calotropis procera on Guinea-pig trachea smooth muscle chain
- 12 February 2005
- Published by Elsevier in Fitoterapia
- Vol. 76 (2) , 250-253
In vitro spasmolytic effect of aqueous extract of Calotropis procera on Guinea-pig trachea smooth muscle chain
- Open Access
- 1 August 2004
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 37 (8) , 1199-1204
Effects of autacoid inhibitors and of an antagonist on malaria infection in mice
The effects of p-chlorophenylalanine, an inhibitor of serotonin synthesis, indomethacin, an inhibitor of prostaglandin synthesis, cyproheptadine, a serotonin, bradykinin and histamine antagonist, were assessed separately and in combination with chloroquine (CQ) in Vom strains of Swiss albino mice (18-22 g) of either sex infected intraperitoneally with 1 x 10(7) Plasmodium yoelii nigeriensis-induced malaria. As prophylactic, these agents reduced from 31.9 +/- 4.5 to 16.1 +/- 8.1% the level of parasitemia relative to control but had no appreciable activity as curative agents when administered subcutaneously once daily for 4 days after 72 h of parasites innoculum in vivo. However, CQ alone and the combination of these agents with CQ in curative and prophylactic treatments significantly reduced (from 50.3 +/- 5.8 to 4.9 +/- 0.75%) the level of parasitemia (P < 0.05), which was taken only once 72 h after the parasites innoculum. The prophylactic result was shown to produce better results than the curative treatment. The data indicate that inhibitors and an antagonist can reduce the parasitemia load (the extent of damage and the severity of infection) as well as enhance the effects of CQ when combined with it for malaria therapy. The study reveals that the production of autacoids in established infection renders autacoid inhibitors and an antagonist ineffective for radical cure in malarial mice; however, selective inhibition of local hormones implicated in the pathological manifestations of malaria infection by autacoid inhibitors and an antagonist may be a possible pathway to reduce the severity of infection and the associated tissue damage and to enhance the efficacy of available anti-malarials.
- 1 August 2004
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 37 (8) , 1199-1204
Open AccessEffects of autacoid inhibitors and of an antagonist on malaria infection in mice
The effects of p-chlorophenylalanine, an inhibitor of serotonin synthesis, indomethacin, an inhibitor of prostaglandin synthesis, cyproheptadine, a serotonin, bradykinin and histamine antagonist, were assessed separately and in combination with chloroquine (CQ) in Vom strains of Swiss albino mice (18-22 g) of either sex infected intraperitoneally with 1 x 10(7) Plasmodium yoelii nigeriensis-induced malaria. As prophylactic, these agents reduced from 31.9 +/- 4.5 to 16.1 +/- 8.1% the level of parasitemia relative to control but had no appreciable activity as curative agents when administered subcutaneously once daily for 4 days after 72 h of parasites innoculum in vivo. However, CQ alone and the combination of these agents with CQ in curative and prophylactic treatments significantly reduced (from 50.3 +/- 5.8 to 4.9 +/- 0.75%) the level of parasitemia (P < 0.05), which was taken only once 72 h after the parasites innoculum. The prophylactic result was shown to produce better results than the curative treatment. The data indicate that inhibitors and an antagonist can reduce the parasitemia load (the extent of damage and the severity of infection) as well as enhance the effects of CQ when combined with it for malaria therapy. The study reveals that the production of autacoids in established infection renders autacoid inhibitors and an antagonist ineffective for radical cure in malarial mice; however, selective inhibition of local hormones implicated in the pathological manifestations of malaria infection by autacoid inhibitors and an antagonist may be a possible pathway to reduce the severity of infection and the associated tissue damage and to enhance the efficacy of available anti-malarials.
- 1 June 2003
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 86 (2-3) , 229-234
Analgesic, antipyretic, anti-inflammatory effects of methanol, chloroform and ether extracts of Vernonia cinerea less leaf
- 1 June 2003
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 86 (2-3) , 229-234
Analgesic, antipyretic, anti-inflammatory effects of methanol, chloroform and ether extracts of Vernonia cinerea less leaf